Status:

COMPLETED

Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic

Lead Sponsor:

Tel Aviv University

Conditions:

Anxiety

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The outbreak of the 2019 Coronavirus (COVID-19) pandemic is a major stressor leading to increased levels of anxiety, and specifically, an excessive fear of being infected and affected by the disease a...

Eligibility Criteria

Inclusion

  • 3 or more symptoms (out of 7) reported in the COVID-19 anxiety inventory with a score of 4 or 5.
  • Fluent Hebrew
  • Having a PC computer at home with internet access

Exclusion

  • A diagnosis of dyslexia or other reading disability

Key Trial Info

Start Date :

April 23 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04365972

Start Date

April 23 2020

End Date

April 30 2020

Last Update

May 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tel Aviv University

Tel Aviv, Israel, 6997801